摘要 |
Method for prediction of risk of thrombotic complications in patients with anti-phospholipid syndrome includes determination of aggregation of thombocytes, thrombocytopenia, activation of PAI-1, protein C and S, activity of bera-2-glicoprotein 1, activity of pro-inflammation cytokines IL-1, IL-6, FNP-alpha. At increase of levels of the last ones one predicts risk of thrombosis. |